CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- Open-market buys, last 90 days
- $22,023,904
- in 7 filings
- Open-market sales, last 90 days
- $4,490,340
- in 8 filings, $4.5M under 10b5-1 plans
Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −2,210 | $29.16 | $64K | 450,035 |
| 2026-10-07 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −1,147 | $30.66 | $35K | 452,245 |
| 2026-10-06 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −3,375 | $32.03 | $108K | 453,392 |
| 2026-09-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −7,925 | $33.04 | $262K | 141,989 |
| 2026-09-30 | Gault Cheryl Chief Operating Officer | Sale 10b5-1 | −2,075 | $33.76 | $70K | 139,914 |
| 2026-09-23 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −1,952 | $39.05 | $76K | 457,025 |
| 2026-09-23 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −215 | $39.86 | $9K | 456,810 |
| 2026-09-23 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −43 | $41.05 | $2K | 456,767 |
| 2026-09-08 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −7,141 | $45.56 | $325K | 460,046 |
| 2026-09-08 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −1,069 | $46.01 | $49K | 458,977 |
| 2026-08-25 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −18,921 | $49.57 | $938K | 467,187 |
| 2026-08-25 | Yeleswaram Krishnaswamy Chief Development Officer | Sale 10b5-1 | −20,799 | $50.31 | $1.0M | 212,063 |
| 2026-08-25 | Yeleswaram Krishnaswamy Chief Development Officer | Sale 10b5-1 | −16,201 | $51.06 | $827K | 195,862 |
| 2026-08-24 | Yeleswaram Krishnaswamy Chief Development Officer | Sale 10b5-1 | −13,160 | $50.00 | $658K | 232,862 |
| 2026-08-19 | Yeleswaram Krishnaswamy Chief Development Officer | Sale 10b5-1 | −404 | $49.90 | $20K | 246,022 |
| 2026-08-11 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −3,664 | $46.90 | $172K | 511,402 |
| 2026-08-11 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −19,500 | $48.04 | $937K | 491,902 |
| 2026-08-11 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −5,794 | $48.62 | $282K | 486,108 |
| 2026-08-10 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −14,171 | $45.97 | $651K | 523,436 |
| 2026-08-10 | Ceesay Abraham Chief Executive Officer | Sale 10b5-1 | −8,370 | $46.75 | $391K | 515,066 |
Page 1 of 5 · 92 trades